跳到主要內容區塊
:::  回新竹臺大首頁 |  體系首頁 |  院長信箱 |  網站導覽 |  RSS  |  English

教學研究活動公告

教學研究活動公告內容
標  題
111/05/27【研究新知】A new perspective on interpretation of bulk gene expression profile changes in perturbational studies for anti-cancer drug discovery
張貼日期
2022-05-23
張貼單位
醫學研究部
內  容

111年05月27日(星期五)12:30-13:30
【研究新知】A new perspective on interpretation of bulk gene expression profile changes in perturbational studies for anti-cancer drug discovery
視訊
主講人:陽明交通大學資訊工程學系 洪瑞鴻教授

One common strategy for studying the effects of an anti-cancer drug is by treating the clone with the drug and seeing what pathways are perturbed by comparing the bulk gene expression profiles before and after the treatment. This strategy works under the assumption that all cells in a clone respond similarly to the treatment.
However, cancer cells are heterogeneous in a clone, there exist diverse Intraclonal subpopulations among which some are more susceptible and some are more resistant to the treatment.  The change in the distribution of subpopulation upon treatment has to be considered when interpreting the changes in the bulk gene expression profiles.
In this talk, I am going to introduce a new computational methodology that learns the subpopulation gene signatures from single-cell RNA sequencing data and applies the knowledge to decompose the bulk expression profiles into a combination of subpopulations. 
Therefore, the dynamics of subpopulations can be recovered and provides a new perspective on the effects of anti-cancer drugs. We applied this approach to one of the world’s biggest perturbational gene expression databases, LNCS L1000 CMap, and demonstrate that the new perspective enabled by our approach can facilitate the discovery of new therapeutics.


歡迎踴躍參加!

資料維護人:醫學研究部 簡助理研究員
關閉快速連結
醫療機構網際網路資訊管理辦法聲明:禁止任何網際網路服務業者轉錄本網路資訊之內容供人點閱。 但以網路搜尋或超連結方式,進入本醫療機構之網址(域)直接點閱者,不在此限。
本網站建議使用Chrome & Firefox & Microsoft Edge瀏覽器 / 螢幕解析度1920*1080以上
版權所有 © 2021 國立臺灣大學醫學院附設醫院新竹臺大分院

TOP